Which plant causes cardiotoxicity involving altered peripheral circulation?

Get ready for the ACVPM Toxicology Exam with our comprehensive quiz. Enhance your knowledge with multiple-choice questions and detailed explanations. Prepare effectively for your certification exam!

Multiple Choice

Which plant causes cardiotoxicity involving altered peripheral circulation?

Explanation:
Cardiotoxicity that involves altered peripheral circulation typically stems from potent vasoconstrictors that reduce blood flow to the extremities. Kentucky 31 tall fescue often harbors an endophytic fungus that produces ergot alkaloids. These compounds mimic sympathetic signaling and activate alpha-adrenergic and serotonergic receptors, causing marked constriction of peripheral blood vessels. The resulting decrease in peripheral perfusion can lead to cold, pale extremities and ischemic issues—hallmarks of vasoconstrictive or “vasospastic” cardiotoxic effects seen with fescue toxicosis. The other plants listed are associated with different toxic effects: one tends toward anticoagulation and bleeding, another toward kidney injury, and the last can cause issues related to oxygen transport or other pathways, not the peripheral vasoconstriction pattern described.

Cardiotoxicity that involves altered peripheral circulation typically stems from potent vasoconstrictors that reduce blood flow to the extremities. Kentucky 31 tall fescue often harbors an endophytic fungus that produces ergot alkaloids. These compounds mimic sympathetic signaling and activate alpha-adrenergic and serotonergic receptors, causing marked constriction of peripheral blood vessels. The resulting decrease in peripheral perfusion can lead to cold, pale extremities and ischemic issues—hallmarks of vasoconstrictive or “vasospastic” cardiotoxic effects seen with fescue toxicosis.

The other plants listed are associated with different toxic effects: one tends toward anticoagulation and bleeding, another toward kidney injury, and the last can cause issues related to oxygen transport or other pathways, not the peripheral vasoconstriction pattern described.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy